Results 161 to 170 of about 22,516 (228)

Unravelling therapeutic resistance: role of cancer stem cell and microRNA in metastatic prostate cancer. [PDF]

Front Mol Biosci
Moondra H, Choudhary GR, Ahirwar DK, Banerjee M, Shukla SK, Shukla KK.   +5 more
europepmc   +1 more source

Cholesterol-Mediated Metabolic-mechanotransductive Crosstalk Orchestrates Castration Resistance in Prostate Cancer. [PDF]

Adv Sci (Weinh)
Liu S, Xu C, Jiang J, He L, Zhou Y, Li Z, Li Y, Zhang K, Yang F, Lu T, Song H, Zhu H, Hu Z, Zhao X, Gan K, Li H, Yang B, Zhang R, Wen W, Han D, Qin W.   +20 more
europepmc   +1 more source

A TBX2-HLX Regulatory Axis Is Associated with Advanced Prostate Cancer. [PDF]

Biomedicines
Raju M, Motakatla PI, Khedmatgozar H, Nandana R, Jiang D, Niu Z, Vafa R, Dutta S, Tripathi M.   +8 more
europepmc   +1 more source

Targeting the Fatty Acid Binding Protein 5-Specificity Protein 1 Axis Restores Enzalutamide Sensitivity by Suppressing Androgen Receptor/Androgen Receptor Splice Variant 7 Signaling: Implications for Prostate Cancer Therapy. [PDF]

World J Oncol
Abdulsamad SA, Naeem AA, Baashar A, Aldarmahi AA, Alamri FF, Abuarab NK, Alsahafi Z, Fallata G, Bokhari A, Alharbi AH, Ke Y, He G.   +11 more
europepmc   +1 more source

3D genome architecture and epigenetic regulation of lineage identity in advanced prostate cancer. [PDF]

Endocrinology
Qi S, Dehm SM.
europepmc   +1 more source

Pleomorphic Giant Cell Carcinoma of the Prostate Treated With Lutetium-177 PSMA. [PDF]

Case Rep Urol
Kwon JY, Cheville JC, Muniz-Rincon M, Ahmed ME, Kwon ED, Riaz I, Childs DS, Johnson G, Sartor O, Pagliaro LC, Orme JJ.   +10 more
europepmc   +1 more source

Imaging Modality and Outcomes of Metastasis-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer: An Updated Analysis of the PRECISE-MDT Cohort. [PDF]

J Nucl Med
Bauckneht M, Belgioia L, Albano D, Triggiani L, Linguanti F, Urso L, Mazzola R, Rizzo A, D'Angelo E, Dondi F, Mataj E, Pedersoli G, Abenavoli EM, Vaggelli L, Detti B, Ortolan N, Malorgio A, Guarneri A, Garrou F, Passoni J, Fiorini M, Grimaldi S, Ghedini P, Iorio GC, Iudicello A, Rovera G, Fornarini G, Zanardi E, Bongiovanni D, Marcenaro M, Agosti A, Timon G, Salgarello M, Racca M, Bartolomei M, Panareo S, Ricardi U, Bertagna F, Alongi F, Barra S, Morbelli S, Lanfranchi F, Sambuceti G.   +42 more
europepmc   +1 more source

The CDK4/6 inhibitor dalpiciclib augments the antitumor efficacy of enzalutamide in preclinical models of castration-resistant prostate cancer through inhibition of MCM4-mediated DNA replication. [PDF]

Cell Death Dis
Liu Y, Ke Y, Yu J, Chai M, Zheng L, Yang C, Liu D, Cheng S, Xiong Z, Feng J, Zhao Z, Wu C, Yu H.   +12 more
europepmc   +1 more source

Integrated Transcriptomic Analysis Identifies Potential Biomarkers in Castration-Resistant Prostate Cancer. [PDF]

World J Oncol
Naeem AA, Abdulsamad SA, Hayat A, Naeem A, Alhazmi N, Fallata G, Bokhari A, Alharbi AH, Alkinani KA, Alshehri AM, Aldabbagh KM.   +10 more
europepmc   +1 more source

Commentary: PCP4 inhibits the progression of prostate cancer through Ca²⁺/CAMKK2/AMPK/AR pathway. [PDF]

Front Immunol
Chen W, Qian F, Wang F, Yang F, Shen Y, Ding M, Liu Y.   +6 more
europepmc   +1 more source